Nā huahana
-
Ka nui o ka Procalcitonin (PCT).
Hoʻohana ʻia ka kit no ka ʻike nui ʻana o ka neʻe ʻana o ka procalcitonin (PCT) i loko o ka serum kanaka, plasma a i ʻole nā koko koko holoʻokoʻa in vitro.
-
hs-CRP + CRP maʻamau
Hoʻohana ʻia kēia kit no ka ʻike in vitro quantitative o ka neʻe ʻana o ka protein C-reactive (CRP) i loko o ka serum kanaka, plasma a i ʻole nā mea hoʻohālike koko holoʻokoʻa.
-
Human Papillomavirus (28 ʻano) Genotyping
Hoʻohana ʻia kēia pahu no ka ʻike qualitative a me ka genotyping o ka nucleic acid o 28 mau ʻano o ka papillomavirus kanaka (HPV6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52 , 53, 54, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83) i loko o ka mimi kāne / wahine a me nā pūnaewele exfoliated cervical cervical, e hāʻawi ana i nā mea kōkua no ka ʻike a me ka mālama ʻana i ka maʻi HPV.
-
28 Nā ʻano o ka maʻi maʻi papilloma kanaka kiʻekiʻe (16/18 paʻi) ʻakika nucleic
He kūpono kēia pahu no ka ʻike in vitro qualitative o 28 ʻano o nā maʻi papilloma kanaka (HPV) (HPV6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 54, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83) ʻakika nucleic i loko o ka mimi kāne / wahine a me nā pūpū exfoliated cervical wahine.Hiki ke paʻi ʻia ka HPV 16/18, ʻaʻole hiki ke paʻi piha ʻia nā ʻano i koe, e hāʻawi ana i mea kōkua no ka ʻike a me ka mālama ʻana i ka maʻi HPV.
-
ʻAiʻiʻo Prostate Specific Antigen (PSA)
Hoʻohana ʻia ka kit no ka ʻike nui ʻana o ka neʻe ʻana o ka prostate specific antigen (PSA) i loko o ka serum kanaka, plasma a i ʻole nā koko koko holoʻokoʻa in vitro.
-
Gastrin 17(G17)
Hoʻohana ʻia ka kit no ka ʻike nui ʻana o ka neʻe ʻana o ka gastrin 17(G17) i loko o ka serum kanaka, plasma a i ʻole nā koko koko holoʻokoʻa in vitro.
-
Pepsinogen I, Pepsinogen II (PGI/PGII)
Hoʻohana ʻia ka kit no ka ʻike nui ʻana o ka neʻe ʻana o ka pepsinogen I, pepsinogen II (PGI/PGII) i loko o ka serum kanaka, plasma a i ʻole nā koko koko holoʻokoʻa in vitro.
-
ʻAiʻokoʻa Prostate Specific Antigen (fPSA)
Hoʻohana ʻia ka kit no ka ʻike in vitro quantitative o ka neʻe ʻana o ka prostate specific antigen (fPSA) i loko o ka serum kanaka, plasma a i ʻole nā mea hoʻohālike koko holoʻokoʻa.
-
Alpha Fetoprotein(AFP) Ka nui
Hoʻohana ʻia ka kit no ka ʻike nui ʻana o ka neʻe ʻana o ka alpha fetoprotein (AFP) i loko o ka serum kanaka, plasma a i ʻole nā koko koko holoʻokoʻa in vitro.
-
Carcinoembryonic Antigen (CEA) Ka nui
Hoʻohana ʻia ka kit no ka ʻike nui ʻana o ka neʻe ʻana o ka carcinoembryonic antigen (CEA) i loko o ka serum kanaka, plasma a i ʻole nā ʻokoʻa koko holoʻokoʻa in vitro.
-
ʻO Enterococcus kū'ē iā Vancomycin a me Gene kū'ē i ka lāʻau
Hoʻohana ʻia kēia kit no ka ʻike qualitative o vancomycin-resistant enterococcus (VRE) a me kāna mau genes kūʻē i ka lāʻau VanA a me VanB i loko o ka sputum kanaka, koko, mimi a i ʻole nā kolone maʻemaʻe.
-
Kanaka Methylated NDRG4/SEPT9/SFRP2/BMP3/SDC2 Gene
Hoʻolālā ʻia ka pahu no ka ʻike in vitro qualitative o nā genes methylated NDRG4/SEPT9/SFRP2/BMP3/SDC2 i loko o nā pūnaewele exfoliated intestinal i loko o nā mea hoʻohālike o ke kanaka.
